NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
October 9, 2025 — Healthcare veteran Aimee Ellis exposes systemic failures in U.S. healthcare in "Flatline Ethics," offering The Ellis Model™ framework for ethical reform and addressing burnout.
October 8, 2025 — Injection Perfection Medical Spa opens new Boca Raton location offering Botox, lip filler, and microneedling treatments. Led by Desirae Lymber, APRN for luxury aesthetic services.
October 8, 2025 — Healthcare Triangle executes warrant exercise agreements securing $478K, with WallachBeth Capital as financial advisor. Digital transformation leader strengthens capital position for healthcare technology growth.
October 8, 2025 — HeartBeam's revolutionary cable-free 12-lead ECG technology promises to transform cardiac diagnostics with portable, clinical-grade monitoring. FDA clearance pending for this groundbreaking innovation.
October 8, 2025 — Monarch Athletic Club expands to Miami Beach at The RIVANI, bringing physician-led wellness with integrated medicine, fitness & recovery services in 2026.
October 8, 2025 — Izotropic Corp advances breast imaging with personalized radiation dose technology in IzoView Breast CT system. $375K funding and market strategy position company in $8.69B global market by 2030.
October 8, 2025 — TransCode Therapeutics acquires Polynoma LLC and secures $25M funding to advance cancer treatments. The deal combines late-stage melanoma vaccine with RNA therapeutics for metastatic disease.
October 8, 2025 — Quantum BioPharma launches $7M whistleblower rewards for stock manipulation evidence. Biopharma company combats market manipulation while advancing neurodegenerative treatments.
October 8, 2025 — Ocumetics reports promising one-month results for revolutionary accommodating intraocular lens. Early clinical data shows patients achieving functional vision without glasses complications.
October 8, 2025 — Oncotelic's Sapu003 injectable Everolimus achieves 100% bioavailability in trials, revolutionizing breast cancer treatment with Deciparticles™ nanotechnology for faster, more effective results.
October 8, 2025 — Izotropic's IzoView Breast CT System aims to revolutionize cancer detection for women with dense breast tissue, addressing $8B in annual diagnostic costs and improving accuracy in the growing $5.4B imaging market.
October 8, 2025 — Oncotelic Therapeutics announces first clinical trial of intravenous Deciparticle everolimus for breast cancer. Phase 1 study enrolling patients in Australia for novel mTOR inhibitor delivery system.
October 8, 2025 — Ohio State researchers discover why immunotherapy fails in most cancer patients, identifying TexPSR stress pathway. Breakthrough could improve treatment for millions.
October 8, 2025 — Nutriband Chairman presents at Noble Capital Markets conference Oct 2025. Learn about their abuse-deterrent fentanyl patch technology and investment opportunities in transdermal pharmaceuticals.
October 8, 2025 — Dr. Amit Khera receives 2025 American Heart Association Chairman's Award for transformative work in preventive cardiology, including NASA's Astro-CHARM calculator and FH screening research.
October 8, 2025 — ABVC BioPharma receives $70K licensing payment from ForSeeCon for Vitargus®, the world's first biodegradable vitreous substitute. Learn about this breakthrough in retinal surgery technology.
October 8, 2025 — Pastor Pretina Hutchinson releases Destiny Blockers memoir, blending mental health expertise with Christian faith to help readers overcome trauma and spiritual barriers.
October 8, 2025 — Rev. Oreste D'Aversa releases "Autism: A Spiritual Perspective" book offering practical tools and spiritual guidance for autism community. Free sample at AutismSpiritualBook.com.
October 8, 2025 — Simflo launches Flosser Y on Kickstarter - an eco-friendly flossing device with quick-change cartridges and biodegradable options. Revolutionize your oral care routine.
October 7, 2025 — Soligenix announces positive safety review for HyBryte™ in Phase 3 CTCL trial. No safety concerns found, enrollment on track for 2025 update. Potential new treatment for rare cancer.